Headquartered in Titusville, New Jersey, Janssen Therapeutics is dedicated to providing innovative virology therapeutics that help healthcare professionals address serious unmet needs in people living with HIV, hepatitis C and other infectious diseases. Our company is focused on sales, marketing, and postmarketing clinical research.
Our partner Janssen Research & Development, LLC is a pharmaceutical research and development company that aims to discover and develop innovative HIV/AIDS and hepatitis C drugs and anti-infectives for diseases of high unmet medical need.
Janssen Therapeutics currently markets 3 antiretroviral HIV medications
(click here for more information about our products).
Janssen Therapeutics is committed to working toward a better future in hepatitis C treatment. This is being achieved through robust internal research & development programs as well as external partnerships evaluating multiple molecules and drug-class combinations across varying stages of development in both interferon-based and interferon-free regimens.
Janssen Therapeutics draws on the scientific expertise and resources of several Janssen companies as well as partnerships with leading external academic institutions and biopharmaceutical companies.
Paralleling the company’s commitment to addressing serious unmet medical needs, Janssen Therapeutics is dedicated to supporting healthcare professionals, patients, and caregivers with support programs and services that reflect high standards of business conduct and
Our Credo values.